News Conference News EuroPCR 2022 Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN Caitlin E. Cox May 27, 2022
News Conference News EuroPCR 2022 Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients Yael L. Maxwell May 27, 2022
News Conference News EAS 2022 Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level Michael O'Riordan May 24, 2022
News Conference News EuroPCR 2022 Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO Yael L. Maxwell May 23, 2022
News Conference News EuroPCR 2022 Better Durability With Self-Expanding TAVI? Clues From UK TAVI Shelley Wood May 18, 2022
News Conference News EuroPCR 2022 JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use Caitlin E. Cox May 18, 2022
News Conference News EuroPCR 2022 Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes Caitlin E. Cox May 17, 2022
Presentation ARCH 2022 Transcatheter Aortic Valve Replacement for LVAD-related AI Presenter: Jeffrey Sparling April 23, 2022
Presentation ARCH 2022 TAVR Deployment: Non-Coronary Isolation & Cusp Overlap Presenter: Nathan L. Frogge April 23, 2022
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
Presentation ACC 2022 Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial Presenter: Duk-Woo Park April 04, 2022
Presentation ACC 2022 5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials Presenter: Michael J. Reardon April 04, 2022
News Conference News ACC 2022 Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years Michael O'Riordan April 04, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022